Ladiratuzumab vedotin

Synonyms: SGN-LIV1A, Anti-LIV-1 ADC

Ladiratuzumab vedotin (SGN-LIV1A, Anti-LIV-1 ADC) is an antibody-drug conjugate (ADC) composed of humanized anti-LIV-1 antibody, conjugated to Monomethyl auristatin E (MMAE), via a proteolytically cleavable type linker. Ladiratuzumab vedotin has the potential for use in multiple carcinomas.

Ladiratuzumab vedotin

CAS No.

Click to purchase products related to Ladiratuzumab vedotin

Purity & Quality Control

Batch: D405701 Purity: 99.15% Protein concentration: 3.21mg/ml Endotoxin Level: <1EU/mg
99.15

Choose Selective Antibody-Drug Conjugate Inhibitors

Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description Ladiratuzumab vedotin (SGN-LIV1A, Anti-LIV-1 ADC) is an antibody-drug conjugate (ADC) composed of humanized anti-LIV-1 antibody, conjugated to Monomethyl auristatin E (MMAE), via a proteolytically cleavable type linker. Ladiratuzumab vedotin has the potential for use in multiple carcinomas.

Product Details

DAR 4.16
ADC antiody ladiratuzumab
ADC linker A proteolytically cleavable type linker
ADC cytotoxin MMAE
Formulation 1xPBS
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Ladiratuzumab vedotin | Ladiratuzumab vedotin supplier | purchase Ladiratuzumab vedotin | Ladiratuzumab vedotin cost | Ladiratuzumab vedotin manufacturer | order Ladiratuzumab vedotin | Ladiratuzumab vedotin distributor